GOSS Gossamer Bio, Inc.: Market Value
This daily price chart for Gossamer Bio, Inc. (GOSS), with a value of 0.07, illustrates the dynamics of a company optimizing global biologic delivery via a network of cold-storage warehouses. Efficient reagent transit ensures the accuracy of medical tests and the safety of therapy. The business is currently competing for the pulmonary hypertension market, where success depends on the trial results of its lead drug candidate.
Comprehensive metric breakdowns and analytics for Gossamer Bio Corp. (GOSS)
- market price and analyst price targets:
- company stock capitalization data:
- book value of equity indicators:
- company liabilities and liquidity data:
Total Debt to Capital Gossamer Bio, Inc.|GOSS - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Gossamer Bio, Inc.|GOSS - Company Aggregate Debts|Debt to Book Capitalization Ratio Gossamer Bio Corp.|GOSS - Company Long-Term Loans and Borrowings|Company Short-Term Debt Gossamer Bio|Quick Ratio gossamerbio.com
- business earnings and investment ratios data:
GOSS - Net Profit|Future Profit Gossamer Bio, Inc.|GOSS - Company Value to Net Income|Forward P/E Multiple Gossamer Corp|GOSS - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Gossamer Bio Corp.|GOSS - Operating profit before deduction of amortization|Earnings per share for the last twelve months Gossamer Bio|GOSS - Net earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months gossamerbio.com|GOSS - Earnings growth in current year|Net earnings per share growth forecast for next year Gossamer Bio, Inc.
Fundamental company analysis:GOSS (Gossamer Bio)
Market capitalization reflects the aggregate value of all the issuer's shares, serving as a gauge of market confidence in future cash flows and the overall financial density of the business. Analyzing the capitalization trend of Gossamer Bio, Inc. (GOSS), an investor can see how the valuation of R&D assets depends on venture financing cycles, despite stable demand in the immunology segment and high operational resilience.
Key competitors
Market Value argenx ARGX|BioNTech Inc. (BNTX) - Market Value|ABVX - Market Value|Market Capitalization ADMA Corp ADMA|Protagonist Therapeutics (PTGX) - Market Value|IMVT - Market Capitalization|Market Value Kiniksa|Grifols SA - Market Valuation|Market Capitalization ADPT|CLDX (Celldex Corp) - Market Value|Market Capitalization AUPH (Aurinia Pharmaceuticals)|Market Capitalization biocryst.com BCRX|VERA - Market Value|Market Value DNTH (Dianthus Therapeutics Inc)|Pharvaris Corp (PHVS) - Market Value|Market Valuation AbCellera Biologics Inc.|TRML (Tourmaline Bio, Inc.) - Market Capitalization|Market Capitalization precigen.com|Market Valuation PHAR (Pharming Group)|NKTR (Nektar Therapeutics Inc) - Market Value|Market Capitalization UPB (Upstream Bio Corp)|Market Capitalization Zenas Corp (ZBIO)|IMNM - Market Value|kalvista.com (KALV) - Market Valuation|Septerna (SEPN) - Market Value|Market Valuation Pieris Pharma|Market Valuation SVRA|Market Capitalization Rigel Corp|Market Value AnaptysBio, Inc. (ANAB)|astriatx.com - Market Capitalization|Market Capitalization ENGN (enGene)|rapt.com (RAPT) - Market Value|Aerovate - Market Capitalization|Market Capitalization Aclaris Therapeutics, Inc (ACRS)|Kyverna Therapeutics (KYTX) - Market Value|Market Value tizianalifesciences.com (TLSA)|Market Value Cabaletta Bio|Ventyx Biosciences Inc. (VTYX) - Market Capitalization|Market Value Theratechnologies Inc (THTX)|Market Capitalization Avalo Therapeutics Inc|Market Capitalization ELDN (Eledon Pharmaceuticals)|Market Capitalization agenusbio.com AGEN|CLYM - Market Value|zurabio.com (ZURA) - Market Valuation|ATYR: Market Capitalization|Market Value Adagene Inc. (ADAG)|Market Value ImageneBio|STTK: Market Value|Market Valuation EQ (Equillium, Inc.)|CNTB (connectbiopharm.com) - Market Value|Market Capitalization IMUX (Immunic)|Atara Biotherapeutics, Inc. - Market Value|InflaRx GmbH - Market Capitalization|Market Capitalization x4pharma.com XFOR|adicetbio.com (ACET) - Market Value|Market Value Celularity (CELU)|Market Valuation INMB|BRNS: Market Value|Market Capitalization KZR|Market Capitalization sabbiotherapeutics.com|Market Value Akari Therapeutics Plc AKTX|ENLV: Market Capitalization|Q32 Bio Corp - Market Capitalization|GeoVax Corp (GOVX) - Market Valuation|EDSA (Edesa Biotech, Inc.) - Market Valuation|IBIO - Market Capitalization|CARM (Carisma Therapeutics Inc) - Market Capitalization|XTLB - Market Capitalization|Market Value Bolt Biotherapeutics (BOLT)|HCWB - Market Value|Market Value Aptevo Therapeutics Inc. APVO|Market Capitalization aimimmuno.com (AIM)|ADTX - Market Value|Market Capitalization GRI Bio Inc GRI|XORTX (XRTX) - Market Value|Market Valuation HIND (Vyome Therapeutics)|REVB (Revelation Biosciences) - Market Capitalization|INDP: Market Value|Market Capitalization SCNI|Market Capitalization calcimedica.com (CALI)|Market Value Affimed N.V. AFMD|Market Value ALLK|HOOK - Market Value|IGM Biosciences, Inc. (IGMS) - Market Valuation|ITOS: Market Capitalization|Ocean Biomedical Inc (OCEA) - Market Capitalization|Market Valuation TCBP|THRD: Market Value
